New Methods for Assessing T-cell Responses

Overview

Journal Clin Diagn Lab Immunol

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2000 Nov 4

PMID 11063487

Citations 32

Authors

N Bercovici

M T Duffour

S Agrawal

M Salcedo

J P Abastado

Affiliations

Soon will be listed here.

Citing Articles

Single cell and TCR analysis of immune cells from AAV gene therapy-dosed Duchenne muscular dystrophy patients.

Emami M, Brimble M, Espinoza A, Owens J, Whiteley L, Casinghino S Mol Ther Methods Clin Dev. 2024; 32(4):101349.

PMID: 39524974 PMC: 11546459. DOI: 10.1016/j.omtm.2024.101349.

Validation of the Enzyme-Linked ImmunoSpot Analytic Method for the Detection of Human IFN-γ from Peripheral Blood Mononuclear Cells in Response to the SARS-CoV-2 Spike Protein.

Carreto-Binaghi L, Nieto-Ponce M, Palencia-Reyes A, Chavez-Dominguez R, Blancas-Zaragoza J, Franco-Mendoza P Biomolecules. 2024; 14(10).

PMID: 39456219 PMC: 11506497. DOI: 10.3390/biom14101286.

De novo identification of CD4 T cell epitopes.

Zdinak P, Trivedi N, Grebinoski S, Torrey J, Martinez E, Martinez S Nat Methods. 2024; 21(5):846-856.

PMID: 38658646 PMC: 11093748. DOI: 10.1038/s41592-024-02255-0.

A whole blood intracellular cytokine assay optimised for field site studies demonstrates polyfunctionality of CD4+ T cells in acute scrub typhus.

Inthawong M, Pinthong N, Thaiprakhong A, Wangrangsimakul T, Sunyakumthorn P, Hill J PLoS Negl Trop Dis. 2023; 17(3):e0010905.

PMID: 36961865 PMC: 10075457. DOI: 10.1371/journal.pntd.0010905.

Human-T-Cell-Selective Fluorescent Probe.

Gao M, Chang Y Cells. 2022; 11(18).

PMID: 36139410 PMC: 9497063. DOI: 10.3390/cells11182836.

References

Fernandez N, Duffour M, Perricaudet M, Lotze M, Tursz T, Zitvogel L . Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects. Cytokines Cell Mol Ther. 1998; 4(1):53-65. View

Givan A, Fisher J, Waugh M, Ernstoff M, Wallace P . A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods. 1999; 230(1-2):99-112. DOI: 10.1016/s0022-1759(99)00136-2. View

Yang J, Lemas V, Flinn I, Krone C, Ambinder R . Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens. Blood. 1999; 95(1):241-8. View

Shankar G, Salgaller M . Immune monitoring of cancer patients undergoing experimental immunotherapy. Curr Opin Mol Ther. 2001; 2(1):66-73. View

Jung T, Schauer U, Heusser C, Neumann C, Rieger C . Detection of intracellular cytokines by flow cytometry. J Immunol Methods. 1993; 159(1-2):197-207. DOI: 10.1016/0022-1759(93)90158-4. View

Wong F, Karttunen J, Dumont C, Wen L, Visintin I, Pilip I . Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med. 1999; 5(9):1026-31. DOI: 10.1038/12465. View

Maccalli C, Pisarra P, Vegetti C, Sensi M, Parmiani G, Anichini A . Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions. J Immunol. 1999; 163(12):6912-23. View

Boon T, van der Bruggen P . Human tumor antigens recognized by T lymphocytes. J Exp Med. 1996; 183(3):725-9. PMC: 2192342. DOI: 10.1084/jem.183.3.725. View

Bousso P, Levraud J, Kourilsky P, Abastado J . The composition of a primary T cell response is largely determined by the timing of recruitment of individual T cell clones. J Exp Med. 1999; 189(10):1591-600. PMC: 2193643. DOI: 10.1084/jem.189.10.1591. View

10.

Jager E, Nagata Y, Gnjatic S, Wada H, STOCKERT E, Karbach J . Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A. 2000; 97(9):4760-5. PMC: 18306. DOI: 10.1073/pnas.97.9.4760. View

11.

Nelson E, Li X, Hsu F, Kwak L, Levy R, Clayberger C . Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood. 1996; 88(2):580-9. View

12.

Herr W, LINN B, Leister N, Wandel E, Meyer zum Buschenfelde K, Wolfel T . The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J Immunol Methods. 1997; 203(2):141-52. DOI: 10.1016/s0022-1759(97)00019-7. View

13.

Shirai A, Sierra V, Kelly C, Klinman D . Individual cells simultaneously produce both IL-4 and IL-6 in vivo. Cytokine. 1994; 6(3):329-36. DOI: 10.1016/1043-4666(94)90030-2. View

14.

Reynolds S, Oratz R, Shapiro R, Hao P, Yun Z, Fotino M . Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. Int J Cancer. 1997; 72(6):972-6. DOI: 10.1002/(sici)1097-0215(19970917)72:6<972::aid-ijc9>3.0.co;2-m. View

15.

Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999; 401(6754):708-12. DOI: 10.1038/44385. View

16.

Crawford F, Kozono H, White J, Marrack P, Kappler J . Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 1998; 8(6):675-82. DOI: 10.1016/s1074-7613(00)80572-5. View

17.

Ogg G, Dunbar P, Romero P, Chen J, Cerundolo V . High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med. 1998; 188(6):1203-8. PMC: 2212532. DOI: 10.1084/jem.188.6.1203. View

18.

Coulie P, Somville M, Lehmann F, Hainaut P, Brasseur F, Devos R . Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int J Cancer. 1992; 50(2):289-97. DOI: 10.1002/ijc.2910500220. View

19.

Kugler A, Stuhler G, Walden P, Zoller G, Zobywalski A, Brossart P . Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med. 2000; 6(3):332-6. DOI: 10.1038/73193. View

20.

Khleif S, Abrams S, HAMILTON J, Chen A, Bastian A, Bernstein S . A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumors. J Immunother. 1999; 22(2):155-65. DOI: 10.1097/00002371-199903000-00007. View